Non-small cell lung cancer

An in-depth report on the causes, diagnosis, treatment, and prevention of non-small cell lung cancer (NSCLC).

I Would Like to Learn About:

Related Reports

Smoking

References

Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e1S-e29S. PMID: 23649439 www.ncbi.nlm.nih.gov/pubmed/23649439.

Araujo LH, Horn L, Merritt RE, Shilo K, Xu-Welliver M, Carbone DP. Cancer of the lung: non-small cell lung cancer and small cell lung cancer. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 69.

Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A Review. JAMA. 2019;322(8):764-774. PMID: 31454018 www.ncbi.nlm.nih.gov/pubmed/31454018.

Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e437S-454S. PMID: 23649451 www.ncbi.nlm.nih.gov/pubmed/23649451.

Ettinger DS, Wood DE, Aisner DL, et al. Non-small cell lung cancer, Version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(4):504-535. PMID: 28404761 www.ncbi.nlm.nih.gov/pubmed/28404761.

Greenhalgh J, Dwan K, Boland A, et al. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer. Cochrane Database Syst Rev. 2016;(5):CD010383. PMID: 27223332 www.ncbi.nlm.nih.gov/pubmed/27223332.

Hanna N, Johnson D, Temin S, et al. Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(30):3484-3515. PMID: 28806116 www.ncbi.nlm.nih.gov/pubmed/28806116.

Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446-454. PMID: 29364287 www.ncbi.nlm.nih.gov/pubmed/29364287.

Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e278S-e313S. PMID: 23649443 www.ncbi.nlm.nih.gov/pubmed/23649443.

Khuri FR. Lung cancer and other pulmonary neoplasms. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 182.

Marmarelis M, Thompson JC, Aggarwal C, et al. Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer. Ann Transl Med. 2017;5(18):380. PMID: 29057240 www.ncbi.nlm.nih.gov/pubmed/29057240.

Mazzone PJ, Silvestri GA, Patel S, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018;153(4):954-985. PMID: 29374513 www.ncbi.nlm.nih.gov/pubmed/29374513.

Osmani L, Askin F, Gabrielson E, Li QK. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Semin Cancer Biol. 2018;52(Pt 1):103-109. PMID: 29183778 www.ncbi.nlm.nih.gov/pubmed/29183778.

PDQ Adult Treatment Editorial Board. Non-small cell lung cancer treatment (PDQ®): Health Professional Version. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.2019 Jun 13. PMID: 26389304 www.ncbi.nlm.nih.gov/pubmed/26389304.

Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e314S-e340S. PMID: 23649445 www.ncbi.nlm.nih.gov/pubmed/23649445.

Rigotti NA. Balancing the benefits and harms of E-cigarettes: A National Academies of Science, Engineering, and Medicine Report. Ann Intern Med. 2018;168(9):666-667. PMID: 29435573 www.ncbi.nlm.nih.gov/pubmed/29435573.

Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based Clinical practice guidelines. Chest. 2013;143(5 Suppl):e142S-e165S. PMID: 23649436 www.ncbi.nlm.nih.gov/pubmed/23649436.

Silvestri GA, Pastis NJ, Tanner NT, Jett JR. Clinical aspects of lung cancer. In: Broaddus VC, Mason RJ, Ernst JD, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 6th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 53.

US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(10):962-970. PMID: 33687470 pubmed.ncbi.nlm.nih.gov/33687470/.

BACK TO TOP

Review Date: 12/13/2019  

Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 08/02/2021.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2021 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.